Stock News

Ghp Investment Advisors Cut West Pharmaceutical Svsc (WST) Holding; Profile of 4 Analysts Covering HomeServe plc (LON:HSV)

Among 8 analysts covering Homeserve PLC (LON:HSV), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Homeserve PLC had 70 analyst reports since August 6, 2015 according to SRatingsIntel. As per Friday, May 27, the company rating was maintained by Liberum Capital. The stock of HomeServe plc (LON:HSV) earned “Neutral” rating by JP Morgan on Wednesday, May 25. The firm earned “Sector Performer” rating on Wednesday, May 24 by RBC Capital Markets. The firm has “Neutral” rating given on Wednesday, May 24 by JP Morgan. The firm earned “Hold” rating on Tuesday, January 23 by Peel Hunt. The company was maintained on Tuesday, August 1 by Liberum Capital. JP Morgan maintained the stock with “Neutral” rating in Thursday, June 30 report. Liberum Capital maintained HomeServe plc (LON:HSV) on Monday, June 26 with “Buy” rating. RBC Capital Markets maintained the shares of HSV in report on Friday, December 18 with “Outperform” rating. Peel Hunt maintained the stock with “Add” rating in Tuesday, November 21 report. See HomeServe plc (LON:HSV) latest ratings:

23/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 850.00 New Target: GBX 850.00 Downgrade
02/01/2018 Broker: JP Morgan Rating: Overweight Upgrade
12/12/2017 Broker: JP Morgan Rating: Overweight Upgrade
30/11/2017 Broker: Jefferies Rating: Underperform Old Target: GBX 630.00 New Target: GBX 680.00 Maintain
30/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 890.00 New Target: GBX 890.00 Maintain
22/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 850.00 New Target: GBX 890.00 Maintain
21/11/2017 Broker: Peel Hunt Rating: Add Old Target: GBX 850.00 New Target: GBX 850.00 Maintain
21/11/2017 Broker: Liberum Capital Rating: Buy New Target: GBX 900.00 Maintain
10/11/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 900.00 New Target: GBX 950.00 Maintain
20/10/2017 Broker: Citigroup Rating: Neutral Old Target: GBX 795.00 New Target: GBX 900.00 Maintain

Ghp Investment Advisors Inc decreased West Pharmaceutical Svsc Inc (WST) stake by 51.35% reported in 2017Q3 SEC filing. Ghp Investment Advisors Inc sold 20,937 shares as West Pharmaceutical Svsc Inc (WST)’s stock rose 14.65%. The Ghp Investment Advisors Inc holds 19,835 shares with $1.91 million value, down from 40,772 last quarter. West Pharmaceutical Svsc Inc now has $6.49 billion valuation. The stock decreased 1.01% or $0.89 during the last trading session, reaching $87.45. About 667,103 shares traded or 97.16% up from the average. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 33.75% since February 17, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. West Pharmaceutical Services had 15 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Hold” rating in Thursday, July 27 report. Jefferies upgraded the stock to “Buy” rating in Friday, September 15 report. The firm has “Outperform” rating by Wells Fargo given on Tuesday, March 22. On Thursday, February 15 the stock rating was maintained by Jefferies with “Buy”. On Wednesday, September 21 the stock rating was downgraded by Wells Fargo to “Market Perform”. The rating was initiated by Janney Capital with “Buy” on Friday, January 8. Bank of America downgraded West Pharmaceutical Services, Inc. (NYSE:WST) rating on Tuesday, October 17. Bank of America has “Hold” rating and $98.0 target. Zacks downgraded West Pharmaceutical Services, Inc. (NYSE:WST) on Tuesday, August 4 to “Hold” rating. The firm has “Outperform” rating given on Friday, October 28 by Wells Fargo. The company was maintained on Thursday, June 29 by Jefferies.

Ghp Investment Advisors Inc increased Littelfuse Inc (NASDAQ:LFUS) stake by 1,735 shares to 20,991 valued at $4.11M in 2017Q3. It also upped Quality Sys Inc (NASDAQ:QSII) stake by 57,736 shares and now owns 170,804 shares. Ishares Tr (IWP) was raised too.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.28, from 1.61 in 2017Q2. It turned negative, as 31 investors sold WST shares while 76 reduced holdings. 42 funds opened positions while 100 raised stakes. 68.09 million shares or 1.49% more from 67.09 million shares in 2017Q2 were reported. Eaton Vance Mgmt has 0.08% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 302,545 shares. 1832 Asset Mgmt Ltd Partnership owns 647,970 shares. 38,000 are held by Rk Management Limited Liability Corp. Aperio Limited Com reported 44,365 shares or 0.02% of all its holdings. Dynamic Management Limited accumulated 18,099 shares or 0.5% of the stock. Bessemer Group stated it has 12,510 shares. Millennium Management Ltd has invested 0% in West Pharmaceutical Services, Inc. (NYSE:WST). World Asset Management Inc accumulated 5,423 shares. Hillsdale Inv Mngmt has invested 0.2% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Ftb Advisors Incorporated holds 0% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST) for 365 shares. State Farm Mutual Automobile Insurance Company has invested 0.01% in West Pharmaceutical Services, Inc. (NYSE:WST). Renaissance Llc reported 420,500 shares. First Quadrant LP Ca owns 279,895 shares. Franklin Resources Inc invested in 3.93 million shares. Paloma Ptnrs Mngmt owns 0% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 3,765 shares.

Since December 8, 2017, it had 0 buys, and 1 sale for $2.08 million activity. The insider FEDERICI WILLIAM J sold 21,000 shares worth $2.08 million.

The stock decreased 0.62% or GBX 4.5 during the last trading session, reaching GBX 718.5. About 461,161 shares traded. HomeServe plc (LON:HSV) has 0.00% since February 17, 2017 and is . It has underperformed by 16.70% the S&P500.

Leave a Reply

Your email address will not be published. Required fields are marked *